HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of quercetin and EGCG on mitochondrial biogenesis and immunity.

AbstractPURPOSE:
To test the influence of 1000 mg of quercetin (Q) with or without 120 mg of epigallocatechin 3-gallate (EGCG), 400 mg of isoquercetin, and 400 mg of eicosapentaenoic acid and docosahexaenoic acid (Q-EGCG) on exercise performance, muscle mitochondrial biogenesis, and changes in measures of immunity and inflammation before and after a 3-d period of heavy exertion.
METHODS:
Trained cyclists (N = 39) were randomized to placebo (P), Q, or Q-EGCG and ingested supplements in a double-blinded fashion for 2 wk before, during, and 1 wk after a 3-d period in which subjects cycled for 3 h x d(-1) at approximately 57% Wmax. Blood, saliva, and muscle biopsy samples were collected before and after 2 wk of supplementation and immediately after the exercise bout on the third day. Blood and saliva samples were also collected 14 h after exercise.
RESULTS:
Two-week supplementation resulted in a significant increase in plasma quercetin for Q and Q-EGCG and granulocyte oxidative burst activity (GOBA) in Q-EGCG. Immediately after the third exercise bout, significant decreases for C-reactive protein (CRP), and plasma interleukin 6 (IL-6) and interleukin 10 (IL-10) were measured in Q-EGCG compared with P. Granulocyte colony-stimulating factor and CRP were reduced in Q-EGCG 14 h after exercise. No group differences were measured in muscle messenger RNA expression for peroxisome proliferator-activated receptor gamma coactivator alpha, citrate synthase, or cytochrome c.
CONCLUSIONS:
Two-week supplementation with Q-EGCG was effective in augmenting GOBA andin countering inflammation after 3 d of heavy exertion in trained cyclists.
AuthorsDavid C Nieman, Dru A Henson, Kendra R Maxwell, Ashley S Williams, Steven R McAnulty, Fuxia Jin, R Andrew Shanely, Thomas C Lines
JournalMedicine and science in sports and exercise (Med Sci Sports Exerc) Vol. 41 Issue 7 Pg. 1467-75 (Jul 2009) ISSN: 1530-0315 [Electronic] United States
PMID19516153 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Antioxidants
  • Fatty Acids, Unsaturated
  • Interleukin-6
  • PPAR gamma
  • RNA, Messenger
  • Interleukin-10
  • Granulocyte Colony-Stimulating Factor
  • Docosahexaenoic Acids
  • Catechin
  • C-Reactive Protein
  • Quercetin
  • Eicosapentaenoic Acid
  • epigallocatechin gallate
Topics
  • Adult
  • Antioxidants (pharmacology)
  • C-Reactive Protein
  • Catechin (analogs & derivatives, pharmacology)
  • Dietary Supplements
  • Docosahexaenoic Acids (pharmacology)
  • Double-Blind Method
  • Eicosapentaenoic Acid
  • Fatty Acids, Unsaturated (blood, pharmacology)
  • Female
  • Granulocyte Colony-Stimulating Factor (blood)
  • Humans
  • Interleukin-10 (blood)
  • Interleukin-6 (blood)
  • Male
  • Mitochondria (drug effects)
  • Oxidative Stress
  • PPAR gamma (drug effects)
  • Quercetin (blood, pharmacology)
  • RNA, Messenger

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: